Press Releases 3 hits

Investment with Impact: Closing the HIV treatment gap

Investment with Impact: Closing the HIV treatment gap

Press Releases   •   May 09, 2014 09:38 GMT

A presentation on the importance of global viral load monitoring to contain the HIV pandemic.

Cavidi and Burnet Institute sign CD4 license agreement

Cavidi and Burnet Institute sign CD4 license agreement

Press Releases   •   Nov 15, 2013 09:29 GMT

Leading Swedish HIV diagnostic company Cavidi today announced the signing of a license agreement for technology in the detection of CD4 T-cell levels. The CD4 test, developed by the Burnet Institute in Melbourne, Australia, and a long time partner to Cavidi, can be added to Cavidi’s Viral Load test on the next generation automated bench top instrument.

Media-no-image

CROI focus shifts to HIV viral load testing in resource-limited settings

Press Releases   •   Feb 26, 2007 12:00 GMT

The need for HIV viral load testing in resource-limited settings was emphasized by researchers from The University of Cape Town and YRG CARE in India at the 2007 Conference on Retroviruses and Opportunistic Infections (CROI). Their research showed the inadequacy of CD4 cell count as a marker of HIV progression and as a tool to combat drug resistance.

News View all 12 hits

From World Trade Center in Malmö to UN in New York

From World Trade Center in Malmö to UN in New York

News   •   Oct 16, 2014 09:12 GMT

Cavidi is working on making diagnostics more accessible. Since Cavidi was founded the company has tried to get closer to the HIV-infected population in the parts of the world that are most affected – that is to say a large part of the developing world. This is being done by taking the lab process out into the field, close to the millions of people who live with HIV.

ExaVir Load proven effective for routine Viral Load in India
Swedish health care delegation visit to India

Swedish health care delegation visit to India

News   •   Feb 29, 2012 15:08 GMT

Helping HIV patients get the best possible treatment

Helping HIV patients get the best possible treatment

News   •   Nov 09, 2010 15:03 GMT

With affordable, effective diagnostic testing, Cavidi is helping physicians provide essential treatment to HIV patients in resource-strapped developing countries.

Blog posts 1 hit

”Getting to Zero” will require more than funding to succeed

”Getting to Zero” will require more than funding to succeed

Blog posts   •   Dec 01, 2011 13:56 GMT

Observations on the role of innovation in the battle against HIV/AIDS

Images 2 hits

HIV treatment scale-up and new WHO ARV guidelines 2013

HIV treatment scale-up an...

GENEVA - New HIV treatment guidelines by WHO recommend offering antiretroviral therapy (ART) earlier. Recent evidence indicates that earl...

License Creative Commons Attribution
Download
Size

254 KB • 893 x 600 px

Swedish health care delegation to India Mr. H.E. Göran Hägglund

Swedish health care deleg...

Mr. H.E. Göran Hägglund, Swedish Minister for Health and Social Affairs address the press conference in Hyderabad, India

License Creative Commons Attribution
Photographer / Source Cavidi
Download
Size

640 x 312 px

Videos 2 hits

Cavendish Global Health Impact Forum - John Reisky, Cavidi CEO

Cavendish Global Health I...

Cavidi CEO, John Reisky de Dubnic, presents a solution to help close a major treatment gap in the global effort to contain the Human Immu...

License Creative Commons Attribution
Download
Size

88.5 MB • 642 x 360 px

CNN airs segment on Cavidi efforts to expand HIV care accessibility

CNN airs segment on Cavid...

Atlanta – CNN broadcasted a feature piece on Cavidi’s ExaVir Load HIV viral load assay. The story centered on Cavidi’s mission to make es...

License Creative Commons Attribution
Download
Size

4.23 MB • 320 x 240 px

Documents 3 hits

MSF report on the development needs in HIV viral load monitoring access

Routine use of viral load testing makes business sense: it will save money on drugs with effective monitoring of patients. MSF identifies the needs of a solution in a wish list on p23. This is the market opportunity that Cavidi is seeking to address with our new platform (Q42014) meeting requirements that MSF have identified for laboratory-based tests. Cavidi ref on p 5,20,21,23,30,and 31.

ExaVir Load Datasheet

ExaVir Load Datasheet

Documents   •   Nov 01, 2011 13:44 GMT

Cavidi awareness ads in AIDS

Cavidi awareness ads in AIDS

Documents   •   May 27, 2008 05:36 GMT

You haven't completed the steps for your Hosted Newsroom

You haven't entered a correct link to your helper.html file for your Hosted Newsroom. Go to Publish and complete the steps.